Ocular Therapeutix Inc (OCUL)
$6.97 -4.65% Close Oct 30, 2026 Live
Ocular Therapeutix stock today
Ocular Therapeutix closed at $6.97 on October 30, 2026, down 4.65% on the day. Over the past year it returned -41.0% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $1.53 billion.
$10.00$15.00
NovJan 2026MarMayJulSep
| Period | OCUL | S&P 500 (SPY) |
|---|---|---|
| 1 month | -9.1% | -0.9% |
| 3 months | -17.7% | +2.1% |
| Year to date | -42.6% | +11.7% |
| 1 year | -41.0% | +12.4% |
| 3 years | +182.2% | +88.5% |
| 5 years | +5.0% | +76.0% |
Key statistics
- Market value
- $1.53B
- Price / sales
- 29.3
- 52-week range
- $6.29 to $16.11
- Next report
- Nov 4, 2026 (estimated)
About Ocular Therapeutix
Ocular Therapeutix develops ophthalmic treatments for dry eye, wet age-related macular degeneration, and related conditions.
Sector: Health Care
More on Ocular Therapeutix
- Financials: revenue, earnings and segmentsRevenue -18% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $1,189 today
No forecast, no recommendation. This page describes Ocular Therapeutix Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.